title: Folate conjugation to polymeric micelles via boronic acid ester to deliver platinum drugs to ovarian cancer cell lines.
abstract: In this study, a novel technique was used for the reversible attachment of folic acid on the surface of polymeric micelles for a tumor-specific drug delivery system. The reversible conjugation is based on the interaction between phenylboronic acid (PBA) and dopamine to form a borate ester. The conjugation is fast and efficient and in vitro experiments via confocal fluorescent microscopy show that the linker is stable in for several hours. Reversible addition-fragmentation chain transfer (RAFT) polymerization was used to synthesize two various sized water-soluble block copolymer of oligoethylene glycol methylether methacylate and methyl acrylic acid (POEGMEMA(35)-b-PMAA(200) and POEGMEMA(26)-b-PMAA(90)). The platinum drug, oxoplatin, was then subsequently attached to the polymer via ester formation leading to platinum loading of 12 wt % as determined by TGA. The platinum-induced amphiphilic block copolymers that consequently led to the formation of micelles of sizes 150 and 20 nm in an aqueous environment with the longer PMAA block forming larger micelles. The small micelles were in addition cross-linked using 1,8-diaminooctane to further stabilize their structure. The targeting ability of folate conjugated polymeric micelles was investigated against two types of tumor cell lines: A549 (-FR) and OVCAR-3 (+FR). The cell line growth inhibitory efficacy of material synthesized was evaluated by using SRB method. The results revealed that folate conjugated micelles showed higher activity in FR + OVCAR-3 cells but not in FR - A549 cells. Similar results were obtained for both small and large micelles without the conjugation of folate. Comparing large and small micelles it can be observed that larger micelles are more efficient, which has been attributed to the lower stability of the smaller micelles. Micelle stabilization via cross-linking could indeed increase the toxicity of the drug carrier.
authors.affiliation: Centre for Advanced Macromolecular Design (CAMD), School of Chemical Engineering, University of New South Wales, Sydney, NSW 2052, Australia.
authors.forename: Wei
authors.initials: W
authors.lastname: Scarano
authors.forename: Hien T T
authors.initials: HT
authors.lastname: Duong
authors.forename: Hongxu
authors.initials: H
authors.lastname: Lu
authors.forename: Paul L
authors.initials: PL
authors.lastname: De Souza
authors.forename: Martina H
authors.initials: MH
authors.lastname: Stenzel
mesh_terms: D000179:Acrylates / Q000737:chemistry; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry; D001897:Boronic Acids / Q000737:chemistry / Q000378:metabolism; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002470:Cell Survival / Q000187:drug effects; D002945:Cisplatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry; D004298:Dopamine / Q000737:chemistry / Q000378:metabolism; D004337:Drug Carriers / Q000737:chemistry; D005260:Female; D005492:Folic Acid / Q000737:chemistry; D006801:Humans; D008738:Methyl Ethers / Q000737:chemistry; D008823:Micelles; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011108:Polymers / Q000138:chemical synthesis / Q000737:chemistry
chemical_list: D000179:Acrylates; D000970:Antineoplastic Agents; D001897:Boronic Acids; D004337:Drug Carriers; D008738:Methyl Ethers; D008823:Micelles; D011108:Polymers; D005492:Folic Acid; C010686:benzeneboronic acid; D002945:Cisplatin; D004298:Dopamine; C043804:diamminedichlorodihydroxyplatinum IV; C035956:methyl acrylate